Buckanovich Lab

Our lab develops new therapies for ovarian cancer, focusing on quiescent CSC & the immune tumor microenvironment @MageeWomens @UPMCHillmanCC

[Buckanovich Lab @BuckanovichLab]

Shifting some of our focus to endometrial cancer.
https://t.co/DJ0Z3U7oiF

[Damon Runyon Cancer Research Foundation @DamonRunyon]

Former Damon Runyon Clinical Investigator @BuckanovichLab and his team set out to understand why only some ovarian cancer patients respond favorably to immune checkpoint inhibitors, and found that the answer lay in the tumor microenvironment. Learn more: https://t.co/bYHAebRyd9

[Magee-Womens Research Institute & Foundation @MageeWomens]

What if we could prevent the recurrence of #ovariancancer? Through critical research, Magee-Womens Research Institute investigators like Dr. Ronald Buckanovich are giving women with cancer new hope. #OvarianCancerAwarenessMonth

Make a gift today: https://t.co/C1qDeWJtQq

[Buckanovich Lab @BuckanovichLab]

A very nice clinical trial from Dr. Lan Coffman

[Buckanovich Lab @BuckanovichLab]

JCI Insight - Phase I trial of ribociclib with platinum chemotherapy in recurrent ovarian cancer https://t.co/6YVp7Rn6Q8

[Buckanovich Lab @BuckanovichLab]

#coffman, #upmchcc

[Buckanovich Lab @BuckanovichLab]

I'm supporting National Ovarian Cancer Coalition! https://t.co/6TS22gS4f2 via @DonorDrive

[Buckanovich Lab @BuckanovichLab]

Targeting therapeutic resistance and multinucleate giant cells in CCNE1-amplified HR-proficient ovarian cancer https://t.co/zLM0ADvOJh

A potential new therapeutic approach for women with hard to treat CCNE1 amplified tumors.

[Buckanovich Lab @BuckanovichLab]

@Penn_OCRC @BasserBRCA @PennGenomeInteg @PennTumor @pennvet @TheWistar @HopkinsGynOnc @PennCancer @fredhutch @CedarsSinai @MageeWomens @DanaFarber Props to Ronny Drapkin for arranging this incredible series.

[Buckanovich Lab @BuckanovichLab]

@BowtellLab @DrLizChristie @PeterMacRes Congrats all!

[Buckanovich Lab @BuckanovichLab]

https://t.co/oiA7zWRVkA
Another interesting paper linking metformin therapy and cancer outcomes.

[Buckanovich Lab @BuckanovichLab]

First patients of pioneering CAR T-cell therapy ‘cured of cancer’ https://t.co/mQgtjCNBqT

[Buckanovich Lab @BuckanovichLab]

Updated perspective on the Hallmarks of Cancer: New Dimensions | Cancer Discovery #cancer #cancerresearch #oncology #science https://t.co/vaYzal5am0

[Buckanovich Lab @BuckanovichLab]

Buckanovich lab is helping to support MWRI's important efforts to facilitate under-represented minorities on a path in science https://t.co/aJPJVf31r8

[Buckanovich Lab @BuckanovichLab]

Celebrating the holidays with a multi-national potluck-- Yumm!

[Buckanovich Lab @BuckanovichLab]

@Vignali_Lab @ScienceTM @BcellBruno Honored to be part of this. Great work!

[Vignali Lab @Vignali_Lab]

Very excited to share our latest paper in @ScienceTM co-led with @BcellBruno on the prevalence of intratumoral Tregs expressing NRP1 and their association with poor outcome in cancer patients. Kudos to my grad student Chris Chuckran who led this study! https://t.co/0fDweUgJhZ

[Journal of Cell Biology @JCellBiol]

.@KellyLeonPSU et al. @airdlab demonstrate that DOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A. https://t.co/96zVJLPU3N

Part of the Year in Cell Biology: 2021 https://t.co/7BZrJIcFnw
#CellBio2021

[Tina's Wish @TinasWish]

It's important to be aware of the signs & symptoms of #OvarianCancer like bloating, upset stomach, frequent urination, feeling full quickly & pelvic pain. Contact your doctor if these symptoms persist for 2+ weeks. Read @Kandigyrl3's full story at https://t.co/sl8P3zPpJ8